Mediates interactions of advanced glycosylation end products(AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. Acts as a mediator of both acute and chronic vascular inflammation in conditions such as atherosclerosis and in particular as a complication of diabetes. AGE/RAGE signaling plays an important role in regulating the production/expression of TNF-alpha, oxidative stress, and endothelial dysfunction in type 2 diabetes. Interaction with S100A12 on endothelium, mononuclear phagocytes, and lymphocytes triggers cellular activation, with generation of key proinflammatory mediators. Interaction with S100B after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling(By similarity). Receptor for amyloid beta peptide. Contributes to the translocation of amyloid-beta peptide(ABPP) across the cell membrane from the extracellular to the intracellular space in cortical neurons. ABPP-initiated RAGE signaling, especially stimulation of p38 mitogen-activated protein kinase(MAPK), has the capacity to drive a transport system delivering ABPP as a complex with RAGE to the intraneuronal space. Can also bind oligonucleotides.
Clonality
monoclonal
Host
Mouse
Immunogen
advanced glycosylation end product-specific receptor
Immunogen Region
advanced glycosylation end product-specific receptor
Isotype
IgG1
Molecular Weight
43 kDa
Reactivity
Human, Rat
Recommended Dilution
WB: 1:1000-1:5000
Synonyms
AGER, RAGE
Uniprot
Q15109
Gene Id
177
Clone No
1B6
Research Area
Developmental biology, Immunology, Signal Transduction
Form
liquid
Purification
protein A+G purified
Purity
>=95% as determined by SDS-PAGE
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months(Avoid repeated freeze / thaw cycles.)
Tested Application
WB: 1:1000-1:5000
Product Manual
<a href="https://www.fn-test.com/content/uploads/product/manuals/antibody/FNab09951.pdf" target="_blank">Data Sheet</ a>